PRODUCT FEATURES
Excellent performance even in compromised situations
Left Main and bifurcation lesions: One of the highest overexpansion capacity for large vessels
6.00mm
75µm
Small vessels:
Adapted to the need of the arteries with thin struts
Diffuse lesions: new available lengths
44 & 49mm
Calcified lesions: excellent arterial support
+40%
vs competitors
High quality of healing
TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer. This mechanism suggest to reduce stent thrombosis.
CLINICAL SUPPORT
Angiolite has proven its safety and efficacy in the following clinical trials and registries
ANGIOLITE Trial
Randomized, non-inferiority, observational, prospective, multicenter trial
at 6 months
Get in touch with us
A sales representative will provide you with the requested information.